Nobuhisa Hagiwara
Department Other, Other Position |
|
Article types | Original article |
Language | English |
Peer review | Peer reviewed |
Title | Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure - A Randomized, Double-Blind, Placebo-Controlled Phase II Study. |
Journal | Formal name:Circulation journal : official journal of the Japanese Circulation Society Abbreviation:Circ J ISSN code:13469843/13474820 |
Domestic / Foregin | Domestic |
Publisher | Japanese Circulation Society |
Volume, Issue, Page | 80(3),pp.668-676 |
Author and coauthor | TSUTSUI Hiroyuki†, MOMOMURA Shinichi, YAMASHINA Akira, OGAWA Hisao, SHIMOKAWA Hiroaki, KIHARA Yasuki, SAITO Yoshihiko, HAGIWARA Nobuhisa, ITO Hiroshi, AKO Junya, INOMATA Takayuki, TANAKA Takashi, KAWASAKI Yasushi, |
Publication date | 2016/02 |
Summary | Ivabradine starting at 2.5 or 5 mg BID effectively reduced resting HR in Japanese HF patients. Ivabradine at the starting dose of 2.5 mg BID could be safer than 5 mg BID. (Circ J 2016; 80: 668-676). |
DOI | 10.1253/circj.CJ-15-1112 |
PMID | 26763489 |